MDwerks Reports Revenue Growth to $524,090 Despite Net Loss in Q2 2026

MDwerks, Inc. reported its financial results for the second quarter of 2026, revealing a revenue increase to $524,090, up from $420,609 in the same period last year. For the first half of 2026, total revenues reached $958,177, compared to $934,539 in the first half of 2025. Despite the revenue growth, the company experienced a net loss of $529,872 for the quarter, a significant improvement from the loss of $1,336,892 reported in the second quarter of 2025. The net loss for the first half of 2026 was $1,376,904, down from $1,966,246 in the prior year.

The company’s cost of revenues decreased to $451,674 for the second quarter of 2026, compared to $701,906 in the same quarter of 2025, contributing to a gross profit of $72,416, a stark contrast to the gross loss of $281,297 reported a year earlier. Operating expenses also saw a reduction, totaling $582,018 for the second quarter, down from $1,043,215 in the previous year. This decline in expenses was attributed to strategic cost management and operational efficiencies.

MDwerks has made significant strides in its operational capabilities, particularly through its subsidiaries, Two Trees Beverage Co. and RF Specialties, LLC. The company has expanded its product offerings, including the introduction of a proprietary Spirits Rapid Aging System, which is expected to enhance production efficiency and product quality. Additionally, MDwerks has entered into contracts for the deployment of this technology, which is anticipated to generate recurring revenue through licensing agreements. The company’s inventory as of June 30, 2026, was reported at $585,007, down from $820,956 at the end of 2025, reflecting a strategic focus on inventory management.

The company’s total assets decreased to $3,890,945 as of June 30, 2026, from $4,048,772 at the end of 2025, primarily due to a reduction in cash and inventory levels. Current liabilities increased to $2,918,412, up from $2,422,069, driven by higher accounts payable and deferred revenue. The accumulated deficit also widened to $7,535,399, compared to $6,158,495 at the end of the previous fiscal year. MDwerks reported a weighted average of 237,579,115 common shares outstanding for the second quarter of 2026, reflecting ongoing capital raising efforts.

Looking ahead, MDwerks anticipates continued revenue growth driven by its innovative product lines and strategic partnerships. However, the company acknowledged the inherent risks and uncertainties in its forward-looking statements, including market conditions and competition. Management remains focused on executing its business plans, which include securing additional financing to support future operations and growth initiatives.